AO-1535
AO-1535 is a semisynthetic monoglycosylceramide that inhibits the production of reactive oxygen intermediates in human monocytes and macrophages stimulated by phorbol ester and chemotactic tetrapeptide. AO-1535 can be used for the research of inflammatory dermatoses[1].
Product Specifications
CAS Number
87178-48-1
UNSPSC
12352005
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ao-1535.html
Smiles
O=C(N[C@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)C2=CC=CN=C2
Molecular Formula
C30H50N2O8
Molecular Weight
566.73
References & Citations
[1]Spampinato G, et al. AO 1535 inhibits O2- production by human macrophages. Immunopharmacology. 1992 Jul-Aug;24 (1) :25-30.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Elab Fluor® 700 Rat IgG2b, κ Isotype Control[LTF-2]](https://cdn.genprice.uk/products/763/68dd1497061270361e7ce068/imageurl/e-ab-f09843m1.webp)
Elab Fluor® 700 Rat IgG2b, κ Isotype Control[LTF-2]
Elab Fluor® 700 Rat IgG2b, κ Isotype Control[LTF-2]
